Objectives
After participating in this educational activity, attendees should be able to:
1| Define heparin resistance
2| Identify causes fir heparin resistance
3| Discuss treatment options for patients with heparin resistance
2| Identify causes fir heparin resistance
3| Discuss treatment options for patients with heparin resistance
Presenter(s):
Larissa Wolfe, PharmD
Larissa Wolfe, PharmD
PGY2 Critical Care Pharmacy Resident
Baystate Medical Center
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
---|---|---|---|
Larissa Wolfe, PharmD | Speaker/Author | No relevant relationships with ineligible companies to disclose | No |
Session date:
01/13/2025 - 2:00pm to 3:00pm EST
Add to calendar:
- 1.00 ACPE Contact Hours